NA
VIR icon

NewEdge Advisors’s Vir Biotechnology VIR Stock Holding History

NewEdge Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$114 – 4383
2025
Q3 		$114 Hold
20
– – ﹤0.01% 4028
2025
Q2 		$101 Hold
20
– – ﹤0.01% 3904
2025
Q1 		$130 Hold
20
– – ﹤0.01% 3820
2024
Q4 		$147 Hold
20
– – ﹤0.01% 3760
2024
Q3 		$150 Buy
+20
New +$174 ﹤0.01% 3699
2023
Q3 		– Sell
-909
Closed -$22.3K – 3671
2023
Q2 		$22.3K Buy
909
+200
+28% +$5.02K ﹤0.01% 2354
2023
Q1 		$16.5K Hold
709
– – ﹤0.01% 2401
2022
Q4 		$18 Buy
+709
New +$17.4K ﹤0.01% 3620

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return